Sandeep Subramanya
Overview
Explore the profile of Sandeep Subramanya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmadani A, Kittana M, Al-Marzooq F, Subramanya S, DAdamo M, Attlee A, et al.
Nutr Res Rev
. 2025 Mar;
:1-65.
PMID: 40079191
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with significant social, communicative, and behavioral challenges, and its prevalence is increasing globally at an alarming rate. Children with ASD often have...
2.
Mf N, Arunachalam S, Sheikh A, Saraswathiamma D, Albawardi A, Al Marzooqi S, et al.
ACS Pharmacol Transl Sci
. 2024 Sep;
7(9):2694-2705.
PMID: 39296269
The potential for multiorgan toxicities is a significant barrier to the therapeutic use of doxorubicin (DOX) in cancer treatment. With regard to DOX-induced acute cardiotoxicity in rats, the current investigation...
3.
Nagoor Meeran M, Arunachalam S, Azimullah S, Saraswathiamma D, Albawardi A, Almarzooqi S, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762315
Cancer chemotherapy with doxorubicin (DOX) may have multiorgan toxicities including cardiotoxicity, and this is one of the major limitations of its clinical use. The present study aimed to evaluate the...
4.
Arunachalam S, Meeran M, Azimullah S, Jha N, Saraswathiamma D, Subramanya S, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142441
Doxorubicin (DOX) is a well-known and effective antineoplastic agent of the anthracycline family. But, multiple organ toxicities compromise its invaluable therapeutic usage. Among many toxicity types, nephrotoxicity is one of...
5.
Das K, Singh R, Subramanya S, Ojha S, Almansoori T, Gokhale D, et al.
Future Virol
. 2021 Sep;
16(9):601-609.
PMID: 34539810
Aim: This study aimed to investigate whether serum biochemical parameters can be used as a surrogate for chest computed tomography (CT) in the diagnosis of COVID-19 in pediatric patients. Materials...
6.
Howarth F, Norstedt G, Boldyriev O, Qureshi M, Mohamed O, Parekh K, et al.
Heliyon
. 2020 Apr;
6(4):e03797.
PMID: 32322744
The physiological role of prolactin (PRL) in the heart, and in particular the diabetic heart, are largely unknown. The effects of PRL on ventricular myocyte shortening and Ca transport in...
7.
Hennig R, Albawardi A, Almarzooqi S, Haneefa S, Imbaraj E, Zaaba N, et al.
Drug Discov Ther
. 2019 Oct;
13(5):248-255.
PMID: 31656252
More than 90% of human pancreatic cancers carry the oncogenic mutant of Ki-RAS and their growth depends on its downstream kinase PAK1, mainly because PAK1 blocks the apoptosis of cancer...
8.
Jahan S, Kumar D, Chaturvedi S, Rashid M, Wahajuddin M, Khan Y, et al.
Curr Med Chem
. 2017 Mar;
24(16):1645-1670.
PMID: 28245768
Inflammasomes are multiprotein complexes having nucleotide-binding domain and leucine-rich repeat consisting members along with pyrin and HIN domain family. An inflammasome mainly consists of cytoplasmic sensor molecule, such as NLRP3,...
9.
Krishnapura P, Belur P, Subramanya S
Crit Rev Microbiol
. 2015 Apr;
42(5):720-37.
PMID: 25865363
l-Asparaginase is one of the main drugs used in the treatment of acute lymphoblastic leukemia (ALL), a commonly diagnosed pediatric cancer. Although several microorganisms are found to produce l-asparaginase, only...
10.
Subramanya S, Ramakrishna B, Binder H, Farthing M, Young G
J Pediatr Gastroenterol Nutr
. 2006 Nov;
43(5):568-75.
PMID: 17130730
Background: Reduced osmolarity oral rehydration solution (ORS) improved small bowel absorption of fluid and electrolytes in segmental perfusion in experimental animals; this was borne out in clinical practice. Adding amylase-resistant...